Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Large Is the Interventional Oncology Market Expected to Be in 2029?
In recent years, the interventional oncology market size has seen significant growth. It’s projected to increase from $2.49 billion in 2024 to $2.72 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.2%. This growth over the historical period can be traced back to factors such as the rise in global cancer cases, wider acceptance of less invasive procedures, increased healthcare investments in developing economies, a growing demand for image-guided therapies, and enhanced understanding of the advantages offered by interventional oncology.
Expectations are high for the interventional oncology market to witness substantial growth in the next several years, with a projection to expand to $3.82 billion by 2029 at a CAGR of 8.8%. The projected growth during the forecast period can be linked to a surge in demand for outpatient oncology procedures, increased usage of combined therapies with immuno-oncology, a rise in clinical trials investigating image-guided therapies, greater access to interventional oncology in developing markets, and the expanding role of precision medicine in formulating treatment plans. Key trends during this forecast period encompass advancements in image-guided ablation technologies, creation of artificial intelligent diagnostic tools, innovations in targeted drug-delivery systems, progress in minimally invasive treatment devices, and the evolution of personalized oncology treatment solutions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27318&type=smp
What Are The Contributors To Demand In The Interventional Oncology Market?
The rise in the frequency of cancer is forecasted to stimulate the expansion of the interventional oncology market. The term cancer prevalence refers to the overall number of individuals, both recently identified and previously recognized, living with a cancer history at a given time. The cancer rate is escalating due to lifestyle-associated risks such as unhealthy eating habits, smoking, drinking alcohol, and exposure to environmental toxins, all of which raise the likelihood of developing different forms of cancer. Interventional oncology contributes to cancer care by offering minimal invasive, tumor-focused therapies. It enhances the patient experience by minimizing damage to healthy tissues and provides faster recuperation times than conventional treatments. For instance, as per the Australian Institute of Health and Welfare, an Australian government organization, the count of cancer diagnoses in Australia hit 160,570 in 2022, signifying an escalation of 3,789 cases from 156,781 in 2021. Consequently, the mounting frequency of cancer is powering the advancement of the interventional oncology market.
What Segmentation Categories Are Included In The Interventional Oncology Market Analysis?
The interventional oncology market covered in this report is segmented
1) By Type: Radiation Therapy Devices, Ablation Devices, Embolization Devices
2) By Technology Type: Ultrasound, Computed Tomography Guided, Magnetic Resonance-Guided
3) By Procedure: Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care
4) By Application Areas: Liver Cancer, Lung Cancer, Kidney Cancer, Pancreatic Cancer, Prostate Cancer
5) By End-Users: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions
Subsegments:
1) By Radiation Therapy Devices: Linear Accelerators, Proton Therapy Systems, Brachytherapy Devices
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Irreversible Electroporation Systems
3) By Embolization Devices: Microspheres, Coil Embolization Devices, Liquid Embolic Agents, Embolic Protection Devices
What Upcoming Trends Are Expected To Impact The Interventional Oncology Market Globally?
Prominent businesses in the sphere of interventional oncology are concentrating their efforts on creating enhanced products like microcatheter-dependent embolization systems. These systems offer accurate cancer treatment, focusing on limiting harm to adjacent healthy tissue. Microcatheter-based embolization systems are medical implements that utilize mini, flexible catheters to accurately distribute embolic agents into blood vessels in order to hinder or lessen blood flow, typically employed for tumors, vascular disorders, or bleeding. As an example, in March 2025, the Occlusafe balloon occlusion catheter was launched by Terumo Corporation, a Japanese medical device firm, building upon its sophisticated Balloon-TACE (B-TACE) therapy, specifically designed for liver cancer treatment, notably hepatocellular carcinoma (HCC). This specialized microcatheter utilizes the pressure gradient effect to reroute blood flow and reach the microcirculation, thereby ensuring high concentrations of therapeutic agents at the tumor location while reducing off-target embolization. This targeted strategy is designed to enhance clinical results in challenging liver cancer cases by bolstering the accuracy of drug delivery and providing superior visualization throughout procedures.
Who Are The Top-Ranked Companies In The Interventional Oncology Market Today?
Major companies operating in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet S.A, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited., Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Minimax Medical Holding Group.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-global-market-report
How Is Interventional Oncology Market Adoption Varying Across Different Regions And Sectors?
North America was the largest region in the interventional oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27318&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model